These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immunization against poliomyelitis. Beale AJ Br Med Bull; 1969 May; 25(2):148-52. PubMed ID: 4319086 [No Abstract] [Full Text] [Related]
6. Advantages and disadvantages of killed and live poliomyelitis vaccines. Melnick JL Bull World Health Organ; 1978; 56(1):21-38. PubMed ID: 307445 [TBL] [Abstract][Full Text] [Related]
7. Standardization of safety and potency tests of vaccines against poliomyelitis. Elisberg BL Rev Infect Dis; 1984; 6 Suppl 2():S519-22. PubMed ID: 6330850 [No Abstract] [Full Text] [Related]
8. Symposium on immunization. Immunization against poliomyelitis. Wehrle PF Arch Environ Health; 1967 Oct; 15(4):485-90. PubMed ID: 6054574 [No Abstract] [Full Text] [Related]
10. Monitoring vaccines for human oncogenicity--discussion. Robbins FC Natl Cancer Inst Monogr; 1968 Dec; 29():457-8. PubMed ID: 4305437 [No Abstract] [Full Text] [Related]
11. Combined use of live and killed vaccines to control poliomyelitis in tropical areas. Melnick JL Dev Biol Stand; 1981; 47():265-73. PubMed ID: 7227655 [No Abstract] [Full Text] [Related]
12. Toward eradication of poliomyelitis by combined use of killed and live vaccines. Melnick JL Cardiovasc Res Cent Bull; 1982; 20(3):49-60. PubMed ID: 6805957 [No Abstract] [Full Text] [Related]
13. Poliomyelitis vaccines. Success and controversy. LaForce FM Infect Dis Clin North Am; 1990 Mar; 4(1):75-83. PubMed ID: 2407779 [TBL] [Abstract][Full Text] [Related]
14. Apropos risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis. Arya SC; Agarwal N Expert Rev Vaccines; 2012 Nov; 11(11):1291. PubMed ID: 23249227 [TBL] [Abstract][Full Text] [Related]
15. An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication. Minor PD Methods Mol Biol; 2016; 1387():1-10. PubMed ID: 26983727 [TBL] [Abstract][Full Text] [Related]
18. [Findings on the success of vaccination and revaccination with live and inactivated vaccines against poliomyelitis]. Dostal V; Haenzel I; Sturm W Schweiz Med Wochenschr; 1969 Sep; 99(37):1322-4. PubMed ID: 4309326 [No Abstract] [Full Text] [Related]
19. Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines. Ogra PL; Faden HS; Abraham R; Duffy LC; Sun M; Minor PD J Infect Dis; 1991 Jul; 164(1):191-4. PubMed ID: 1647422 [TBL] [Abstract][Full Text] [Related]
20. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis. Pliaka V; Kyriakopoulou Z; Markoulatos P Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]